Found 8 matching trials
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
PHASE3This is an open-label, randomized, multicenter, efficacy and safety study o...
Location
Children's Hospital of Orange County- Children's Clinic
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
PHASE2Protocol CP-4-004-OLE (Open Label Extension) is designed as a long-term, op...
Location
Nemours Children's Clinic
MOD-4023 Study in Healthy Male Volunteers
PHASE1This study aims to examine the safety, tolerability and pharmacokinetics of...
Location
Tel Aviv Sourasky Medical Center
Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
PHASE2This is a phase II, open label, active-controlled, randomized safety and do...
Location
Children's Hospital "P. A. Kyriakou"
A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency
PHASE3This will be a randomized, double-blind, placebo-controlled, parallel-group...
MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)
PHASE2This study aims to assess the safety, tolerability and Pharmacokinetics/ Ph...
Location
Internal Clinic in University Hospital St. Anna
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
PHASE3Treatment of children with growth failure due to growth hormone deficiency ...
Location
Aichi Medical University Hospital
Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers
PHASE1The study is a Phase 1, randomized, double-blind, vehicle-controlled, singl...